Tempus AI is trading at $65.24, down 4.50% in pre-market amid broad technology and market pressure.

  • No new company-specific catalyst surfaced; its latest highlighted collaboration with Moderna and Merck was announced October 7.
  • Hotter-than-expected U.S. inflation renewed rate concerns; Reuters reported a deeper selloff in AI-related stocks and falling Nasdaq futures.
  • The Nasdaq was down 1.30%, making the decline appear consistent with broad market pressure rather than a confirmed company-specific event.